The 19th Annual Health Care Conference - Piper Jaffray · The 19th Annual Health Care Conference November 27–29, 2007, New York City You are invited to attend

Industry Expertise: Alternative Energy | Business Services | Consumer |

Financial Institutions | Health Care | Industrial Growth | Technology

The 19th Annual

Health Care ConferenceNovember 27-29, 2007, New York City

The 19th Annual

Health Care ConferenceNovember 27–29, 2007, New York City

You are invited to attend

INTRODUCTIONPiper Jaffray cordially invites you to attend the 19th Annual Health Care Conference. The traditional fundamental attributes and forward-growth prospects exhibited by the health care sector will be a key component to investing strategies in the New Year.

This year’s conference will host nearly 300 companies spanning the biotechnology, specialty pharmaceuticals, drug discovery, medical technology, medical diagnostics & devices, and health care services sectors.

Management teams from participating public companies will have 30 minutes allotted for company overview presentations and informal Q&A sessions. Industry experts, physicians, and academicians have also been invited to host panels and address topics of regulatory, reimbursement, and legal issues. Further granularity will be presented in disease specific discussions on atherosclerosis, diabetes, cancer and other areas of interest to investors.

The conference will feature nearly 100 top health care private companies, based on their later stage of development, business models and influential technology. These sessions should be of particular interest to private equity investors and venture capitalists.

DATES & LOCATIONNovember 27-29, 2007

The Pierre HotelFifth Avenue at 61st StreetNew York, NY 10021 212 838-8000

CONFERENCE REGISTRATIONTo register for the 19th Annual Health Care Conference, please visit our conference Web Site at www.piperjaffray.com/hcc.

Questions? Contact the conference information line at 800 333-6000, ext. 36074, or e-mail [email protected].

This conference is by invitation only and offered at no cost to active Piper Jaffray clients. You must register in advance to attend.

SCHEDULEInformation regarding the schedule, presenting companies, panel discussions and featured speakers will be updated and posted on our conference Web site at www.piperjaffray.com/hcc.

Tuesday, November 27• Public and private company presentations from 8:00 a.m. – 5:00 p.m.• Panel discussion• Featured speaker• One-on-one and small group meetingsWednesday, November 28• Public and private company presentations from 8:00 a.m. – 5:00 p.m.• Panel discussions• One-on-one and small group meetingsThursday, November 29• One-on-one and small group meetings• No company presentations

ACCOMMODATIONSPlease visit the event Web Site at www.piperjaffray.com/hcc for a list of hotels near the conference site.

ATTIREBusiness attire is appropriate.

The 19th Annual Health Care Conference

PRESENTING COMPANIES (as of October 24, 2007)

3SBio Inc.ABIOMED, Inc.ACADIA Pharmaceuticals Inc. Access Closure, Inc. Acclarent, Inc. Accuray Incorporated Acorda Therapeutics, Inc. Advanced Medical Optics, Inc. Affymetrix, Inc. AGA Medical Corporation Agensys, Inc. Aldagen, Inc. Alexza Pharmaceuticals, Inc. Align Technology, Inc. Alimera Sciences, Inc. Alizyme Plc ALK-Abelló A/S Alliance Imaging, Inc. Allion Healthcare, Inc. Allscripts Healthcare Solutions, Inc. Alnylam Pharmaceuticals, Inc. American Medical Systems Holdings, Inc. American Oriental Bioengineering, Inc. Anadys Pharmaceuticals, Inc. Anesiva, Inc. AngioDynamics, Inc. AngioScore, Inc.

Animal Health International, Inc. Antisoma Plc Anulex Technologies, Inc. Applied Biosystems Group ARCA Discovery, Inc. Ardana Plc Ardea Biosciences, Inc. Arena Pharmaceuticals, Inc. Array BioPharma Inc. ArthroCare Corporation Asthmatx, Inc. Asuragen, Inc. athenahealth, Inc. AtriCure, Inc. Atritech, Inc. ATS Medical, Inc. Aureon Laboratories, Inc. Aurora Diagnostics, LLC Auxilium Pharmaceuticals, Inc. AxioMed Spine Corporation Axis-Shield BÂRRX Medical, Inc. Beckman Coulter, Inc. BioPro Pharmaceutical, Inc. BioScrip, Inc. Boston Scientific Corporation BTG plc

C.R. Bard, Inc. Caliper Life Sciences, Inc. Calypso Medical Technologies, Inc. Cameron Health, Inc. CareMedic Systems, Inc. CBL Path, Inc. Celator Pharmaceuticals, Inc. Celera Group Celgene Corporation Centene Corporation Cepheid Cerner Corporation CoAxia, Inc. CombinatoRx, Incorporated Cooper Companies, Inc. (The) Corin Group Plc Cryolife, Inc. Curalogic A/S Cutera, Inc. CV Therapeutics, Inc. CVRx, Inc. Cyberonics, Inc. Cytochroma, Inc. Cytori Therapeutics, Inc. Dauphin Capital Partners deCODE Genetics, Inc. DexCom, Inc.


Disc Dynamics, Inc. DURECT Corporation eBioscience Corporation Echo Healthcare Acquisition Corporation Eclipsys Corporation Emageon Inc. ENANTA Pharmaceuticals, Inc. Endo Pharmaceuticals Holdings Inc. EraGen Biosciences, Inc. ev3 Inc. Evalve, Inc. Evotec AG Exelixis, Inc. FlowCardia, Inc. Fluidigm Corp. Forest Laboratories, Inc. Genentech, Inc. Genmab A/S Genomic Health, Inc. Gen-Probe Incorporated GenVault Corporation Gilead Sciences, Inc. GlobeImmune, Inc. GPC Biotech AG Greatbatch, Inc. Greenway Medical Technologies, Inc. Gyrus Group Plc Hansen Medical, Inc. HealthPlan Holdings, Inc. Healthways, Inc.

Home Diagnostics, Inc. Human Genome Sciences, Inc. Illumina, Inc. ImClone Systems Incorporated Immucor, Inc. Incyte Corporation Indigo Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc. InnerPulse, Inc. Innovation Factory, L.L.C. (The) Integra LifeSciences Holdings Corporation Intuitive Surgical, Inc. IRIS International, Inc. ISIS Pharmaceuticals, Inc. Jerini AG K2M, Inc. KAI Pharmaceuticals, Inc. Kémia, Inc. Kensey Nash Corporation Lanx, LLC LDR Spine USA, Inc. Lexicon Pharmaceuticals, Inc. LifeCell Corporation LipoSonix, Inc. Locus Pharmaceuticals, Inc. LuxBio Sciences, Inc. MacroGenics, Inc. MannKind Corporation Masimo Corporation Matria Healthcare, Inc.

MDVIP, Inc. MED3000, Inc. Medem, Inc. MedSynergies, Inc. Medtronic, Inc. Mentor Corporation Metabolex, Inc. MethylGene Inc. Microbia, Inc. Micrus Endovascular Corporation Millennium Pharmaceuticals, Inc. Monogram Biosciences, Inc. MWI Veterinary Supply, Inc. Myriad Genetics, Inc. Neurocrine Biosciences Inc. NeuroMetrix, Inc. NicOx SA Nighthawk Radiology Holdings, Inc. Novadaq Technologies Inc. NovaMed, Inc. Novare Surgical Systems Novasys Medical, Inc. Nursefinders, Inc. NxStage Medical, Inc. Omnicell, Inc. OnCure Medical Corp. Optimer Pharmaceuticals, Inc. OraMetrix, Inc. Oscient Pharmaceuticals Corporation OSI Pharmaceuticals, Inc.


Paracor Medical Inc. Paratek Pharmaceuticals, Inc. Passport Health Communications, Inc. Pathway Medical Technologies, Inc. Pharmion Corporation Phase Forward Incorporated Physician Oncology Services Picis, Inc. Possis Medical, Inc. Premier Bathrooms Progenics Pharmaceuticals, Inc. ProStrakan Group Plc Protherics plc Purkinje, Inc. QIAGEN N.V. Quality Systems, Inc. Radiation Therapy Services, Inc. Radius Health, Inc. RadNet, Inc. RadPharm, Inc. Regado Biosciences, Inc. ResCare, Inc. Salix Pharmaceuticals, Ltd. Sanarus Medical, Inc. Sangamo BioSciences, Inc. Santhera Pharmaceuticals Sciele Pharma, Inc. SearchAmerica, Inc. SGX Pharmaceuticals, Inc. SHPS

Sirtris Pharmaceuticals, Inc. SkinMedica, Inc. SkyePharma Somaxon Pharmaceuticals, Inc. Sonic Innovations, Inc. Source Medical Solutions, Inc. Spectranetics Corporation (The) Spectrum Laboratory Network Spheris Inc. SpinalMotion, Inc. Stereotaxis, Inc. Stryker Corporation Supplemental Health Care Services, Inc. Surface Logix Inc. SurgRx, Inc. Symmetry Medical Inc. TEI Biosciences Inc. Tengion Inc. Third Wave Technologies, Inc. TissueLink Medical, Inc. TomoTherapy Incorporated Transcept Pharmaceuticals, Inc. Transport Pharmaceuticals, Inc. Tranzyme Pharma, Inc. TriZetto Group, Inc. (The) Universal Hospital Services, Inc. Vantage Oncology, Inc. VCA Antech, Inc. Vectura Group Plc Ventracor Limited

Vernalis PlcVidaCare CorporationViroPharma IncorporatedVital Images, Inc.Vital Signs, Inc.VNUS Medical Technologies, Inc.Volcano CorporationWright Medical Group, Inc.Xoft Inc.XTENT, Inc.Zimmer Holdings, Inc.ZOLL Medical CorporationZymoGenetics, Inc.



Schedule as of: October 29, 2007 Schedule is subject to change.

19th Annual Piper Jaffray Health Care Conference Tuesday, November 27 – Thursday, November 29, 2007

The Pierre Hotel, New York

1 of 4

Tuesday,November 27

Track One Grand Ballroom

Track Two Cotillion Room

Track Three Wedgwood Room

Track Four Wedgwood Room

Track Five Wedgwood Salon

Track Six Regency A

Track Seven Regency B

8:00 – 8:30 Medtronic, Inc. (MDT) Affymetrix, Inc. (AFFX) Vectura Group Plc

(VEC LN)

SomaxonPharmaceuticals, Inc.

(SOMX)

CombinatoRx, Incorporated (CRXX)

Private Company Presentations

8:30 TissueLink Medical, Inc.

Aurora Diagnostics, LLC8:30 – 9:00 OSI Pharmaceuticals,

Inc. (OSIP) Masimo Corporation

(MASI) Curalogic A/S (CUR

DC)XTENT, Inc. (XTNT)

Cytori Therapeutics, Inc. (CTYX)

8:50 Cameron Health, Inc. Passport Health

Communications, Inc.

9:00 – 9:30 Zimmer Holdings, Inc. (ZMH)

Cepheid (CPHD) Phase Forward Incorporated

(PFWD)

SantheraPharmaceuticals

(SANN SW)

AnadysPharmaceuticals, Inc.

(ANDS) 9:10 Disc Dynamics, Inc. Vantage Oncology, Inc.

9:30Indigo

Pharmaceuticals, Inc. Picis, Inc. 9:30 – 10:00 Stryker Corporation

(SYK)Applied Biosystems

Group (ABI) Vital Signs, Inc.

(VITL) Cutera, Inc. (CUTR)

OptimerPharmaceuticals, Inc.

(OPTR) 9:50 Acclarent, Inc. Premier Bathrooms

10:00 – 10:30 Eclipsys Corporation

(ECLP) Company to be

announcedIncyte Corporation

(INCY) NovaMed, Inc.

(NOVA)10:10 CoAxia, Inc. RadPharm, Inc.

10:30 Pathway Medical Technologies, Inc.

Transcept Pharmaceuticals, Inc. 10:30 – 11:00

Keynote Address: Lois Quam, Head of

Alternative Investments, Piper Jaffray & Co.

ISIS Pharmaceuticals, Inc. (ISIS)

MannKindCorporation

(MNKD)

ABIOMED, Inc. (ABMD)

NeuroMetrix, Inc. (NURO)

10:50 Novasys Medical, Inc. Paratek

Pharmaceuticals, Inc.

11:00 – 11:30 Gilead Sciences, Inc.

(GILD) Quality Systems, Inc.

(QSII)ResCare, Inc. (RSCR) Immucor, Inc. (BLUD) BioScrip, Inc. (BIOS) 11:10 MED3000, Inc. Asthmatx, Inc.

11:30Greenway Medical Technologies, Inc.

Asuragen, Inc. 11:30 – 12:00 Genmab A/S (GEN DC)

Gyrus Group Plc (GYG LN)

Hansen Medical, Inc. (HNSN)

Caliper Life Sciences, Inc. (CALP)

SGX Pharmaceuticals, Inc. (SGXP)

11:50 MedSynergies, Inc. Metabolex, Inc.

12:00 – 12:30 Celgene Corporation (CELG)

LifeCell Corporation (LIFC)

ZOLL Medical Corporation (ZOLL)

Third Wave Technologies, Inc.

(TWTI)

Company to be announced 12:10

Supplemental Health Care Services, Inc.

Microbia, Inc.

12:30 LuxBio Sciences, Inc. GenVault Corporation 12:30 – 1:00 Accuray Incorporated (ARAY)

American Oriental Bioengineering, Inc.

(AOB)

Company to be announced

DexCom, Inc. (DXCM) Universal Hospital

Services, Inc. 12:50MethylGene Inc.

(TSX MYG) eBioscienceCorporation

1:00 – 1:30 Cooper Companies, Inc. (The) (COO)

ev3 Inc. (EVVV) Antisoma Plc

(ASM LN)

NeurocrineBiosciences Inc.

(NBIX)

InfinityPharmaceuticals, Inc.

(INFI) 1:10

AGA Medical Corporation

Medem, Inc.

1:30 Atritech, Inc. Locus Pharmaceuticals,

Inc.1:30 – 2:00 Greatbatch, Inc. (GB)

IRIS International, Inc. (IRIS)

Cryolife, Inc. (CRY) 1:50 Lanx, LLC

ENANTAPharmaceuticals, Inc.

2:00 – 2:30

Panel: Investing In The Chinese Healthcare

Sector athenahealth, Inc. (ATHN)

AngioDynamics, Inc. (ANGO)

ProStrakan Group Plc (PSK LN) 2:10 BÂRRX Medical, Inc. GlobeImmune, Inc.





2 of 4

Tuesday,November 27






Track Six Regency A


2:30 FlowCardia, Inc. Fluidigm Corp. 2:30 – 3:00

Mentor Corporation (MNT)

ZymoGenetics, Inc. (ZGEN)

NxStage Medical, Inc. (NXTM)

Protherics plc (PIT LN) 2:50 Evalve, Inc. Aldagen, Inc.

3:00 – 3:30 Cerner Corporation (CERN)

Wright Medical Group, Inc. (WMGI)

Monogram Biosciences, Inc.

(MGRM)

SkyePharma(SKP LN) 3:10 AngioScore, Inc. Agensys, Inc.

3:30Source Medical Solutions, Inc.

BioPro Pharmaceutical, Inc.3:30 – 4:00 ALK-Abelló A/S (ALKB

DC)

AuxiliumPharmaceuticals, Inc.

(AUXL)

Company to be announced

AlexzaPharmaceuticals, Inc.

(ALXA) 3:50 SpinalMotion, Inc. Regado Biosciences,

Inc.

4:00 – 4:30 Allscripts Healthcare

Solutions, Inc. (MDRX)

ArenaPharmaceuticals, Inc.

(ARNA)

DURECT Corporation (DRRX)

Vernalis Plc(VER LN) 4:10

AxioMed Spine Corporation

KAI Pharmaceuticals, Inc.

4:30 – 5:00 QIAGEN N.V. (QGEN) 3SBio Inc. (SSRX) Anesiva, Inc. (ANSV) Novadaq Technologies

Inc. (TSX NDQ)

Since 1895. Member SIPC and FINRA. Securities and products are offered in the United Kingdom through Piper Jaffray Ltd., which is an affiliate of Piper Jaffray & Co., incorporated under the laws of England and Wales, authorized and regulated by the Financial Services Authority and a member of the London Stock Exchange.

*Schedule as of October 24, 2007. Subject to change.





3 of 4

Wednesday, November

28






Track Six Regency A


8:00 – 8:30 Beckman Coulter, Inc. (BEC)

AlnylamPharmaceuticals, Inc.

(ALNY)

Acorda Therapeutics, Inc. (ACOR)

Sonic Innovations, Inc. (SNCI)

Ardana Plc (ARA LN) Private Company Presentations

8:30 TEI Biosciences Inc. SkinMedica, Inc.

8:30 – 9:00 Endo Pharmaceuticals Holdings Inc. (ENDP)

Healthways, Inc. (HWAY)

Axis-Shield (ASD LN)

LexiconPharmaceuticals,

Inc. (LXRX)

ATS Medical, Inc. (ATSI)

8:50 SurgRx, Inc. Celator Pharmaceuticals,

Inc.

9:00 – 9:30 Boston Scientific Corporation (BSX)

ArthroCare Corporation (ARTC)

SpectraneticsCorporation (The)

(SPNC)

deCODE Genetics, Inc. (DCGN)

Allion Healthcare, Inc. (ALLI)

9:10 Sanarus Medical, Inc. Tengion Inc.

9:30Calypso Medical

Technologies, Inc. Transport Pharmaceuticals,

Inc.9:30 – 10:00 Myriad Genetics, Inc. (MYGN)

Cyberonics, Inc. (CYBX)

Home Diagnostics, Inc. (HDIX)

Ardea Biosciences, Inc. (ARDC)

9:50 LipoSonix, Inc. Tranzyme Pharma, Inc.

10:00 – 10:30

Health Services Panel

Human Genome Sciences, Inc. (HGSI)

Micrus Endovascular Corporation

(MEND)

Animal Health International, Inc.

(AHI)AtriCure, Inc. (ATRC) 10:10 Paracor Medical Inc. Cytochroma, Inc.

10:30 Access Closure, Inc. SearchAmerica, Inc. 10:30 – 11:00 Gen-Probe Incorporated (GPRO)

TriZetto Group, Inc. (The) (TZIX)

Possis Medical, Inc. (POSS)

ACADIAPharmaceuticals Inc.

(ACAD)

Echo Healthcare Acquisition Corp.

(EHHA OB) 10:50 InnerPulse, Inc. CareMedic Systems, Inc.

11:00 – 11:30 Align Technology, Inc. (ALGN)

American Medical Systems Holdings, Inc.

(AMMD)

Matria Healthcare, Inc. (MATR)

SangamoBioSciences, Inc.

(SGMO)

OscientPharmaceuticals

Corporation (OSCI) 11:10

Innovation Factory, L.L.C. (The)

CBL Path, Inc.

11:30 CVRx, Inc. Spheris Inc. 11:30 – 12:00 MillenniumPharmaceuticals, Inc.

(MLNM)

Pharmion Corporation (PHRM)

Stereotaxis, Inc. (STXS)

Alliance Imaging, Inc. (AIQ)

SirtrisPharmaceuticals, Inc.

(SIRT) 11:50 Novare Surgical Systems Spectrum Laboratory

Network

12:00 – 12:30 Omnicell, Inc. (OMCL) Kensey Nash

Corporation (KNSY) Evotec AG (EVT GR)

MWI Veterinary Supply, Inc. (MWIV) 12:10 Xoft Inc. SHPS

12:30 K2M, Inc. MDVIP, Inc. 12:30 – 1:00 Prostate Cancer Panel

Advanced Medical Optics, Inc. (EYE)

Corin Group Plc (CRG LN)

Alizyme Plc (AZM LN)

Company to be announced 12:50 LDR Spine USA, Inc. Purkinje, Inc.

1:00 – 1:30 Intuitive Surgical, Inc.

(ISRG) ImClone Systems

Incorporated (IMCL) Genomic Health,

Inc. (GHDX) Emageon Inc.

(EMAG) RadNet, Inc.

(RDNT) 1:10 VidaCare Corporation Company to be announced

1:30 Nursefinders, Inc. OnCure Medical Corp. 1:30 – 2:00 C.R. Bard, Inc. (BCR) Illumina, Inc. (ILMN) Centene Corporation

(CNC)

SalixPharmaceuticals,

Ltd. (SLXP) 1:50 Company to be announced Aureon Laboratories, Inc.





4 of 4

Wednesday, November

28






Track Six Regency A


2:00 – 2:30 Radiation Therapy

Services, Inc. (RTSX) Symmetry Medical

Inc. (SMA) BTG plc (BGC LN) 2:10 Alimera Sciences, Inc. MacroGenics, Inc.

2:30 Anulex Technologies, Inc. Kémia, Inc. 2:30 – 3:00

Hospital-Acquired Infection Panel

TomoTherapyIncorporated (TTPY)

Nighthawk Radiology Holdings, Inc.

(NHWK)

Array BioPharma Inc. (ARRY) 2:50 OraMetrix, Inc. Surface Logix Inc.

3:00 – 3:30 Genentech, Inc. (DNA) Volcano Corporation

(VOLC)NicOx SA (COX FP)

GPC Biotech AG (GPC GR) 3:10 ARCA Discovery, Inc. HealthPlan Holdings, Inc.

3:30 Radius Health, Inc. EraGen Biosciences, Inc. 3:30 – 4:00

Forest Laboratories, Inc. (FRX)

Celera Group (CRA) CV Therapeutics, Inc. (CVTX) TW

Exelixis, Inc. (EXEL) 3:50 Company to be announced Company to be announced

4:00 – 4:30 VCA Antech, Inc. (WOOF) ViroPharma

Incorporated (VPHM)

ProgenicsPharmaceuticals,

Inc. (PGNX)

VNUS Medical Technologies, Inc.

(VNUS) 4:10 Company to be announced Company to be announced

4:30 – 5:00 Integra LifeSciences

Holdings Corporation (IART)

Sciele Pharma, Inc. (SCRX)

Jerini AG (JI4 GR) Vital Images, Inc.

(VTAL)

Thursday, November 29 One-on-one’s – Schedules may be picked up in the Wedgwood Room Lower Level

Conference Location: The Pierre Hotel, Fifth Avenue at 61st Street, New York, NY

Since 1895. Member SIPC and FINRA. Securities and products are offered in the United Kingdom through Piper Jaffray Ltd., which is an affiliate of Piper Jaffray & Co., incorporated under the laws of England and Wales, authorized and regulated by the Financial Services Authority and a member of the London Stock Exchange.

*Schedule as of October 24, 2007. Subject to change.

HEALTH CARE SERVICES: ALTERNATE SITE PROVIDERS

Mark L. ArnoldSenior Research Analyst612 [email protected]

Mark Arnold is a vice president and senior research analyst at Piper Jaffray, following high yield and equity issuers in the health care services space.

Prior to joining Piper Jaffray in 2005, Arnold was a marketer at 3M Company, where he managed numerous products under the Post-it, Scotch, and 3M Brands. He also spent five years as a health care consultant for Clark Consulting, working with hospital systems and their affiliated physician groups on network strategy and operations, compensation and productivity, reimbursement and physician affiliation models.

Arnold holds a bachelor of science degree in mechanical engineering from Columbia University in New York, NY, and a master’s degree in business administration from the University of Michigan Business School in Ann Arbor, MI.

AssociatesBradley D. Fisher612 [email protected]

Daniel P. Katan612 [email protected]

CompaniesAlliance Imaging, Inc.AmSurg Corp.Community Health Systems, Inc.DaVita Inc.Fresenius Medical Care AGIASIS Healthcare CorporationInSight Health Services Corp.NovaMed, Inc.Psychiatric Solutions, Inc.Radiation Therapy Services, Inc.Radiologix, Inc.Renal Care Group, Inc.Tenet Healthcare CorporationTriad Hospitals, Inc.US Oncology, Inc.Vanguard Health Systems, Inc.


EUROPEAN BIOTECHNOLOGY

Sam M. Fazeli, Ph.D.Senior Research Analyst011 44 20 [email protected]

Sam Fazeli is a managing director, deputy head of European research, and senior research analyst focused on European biopharmaceutical stocks. He

has 11 years of experience in the biopharmaceutical sector and was ranked No. 2 in the Extel Biotech Survey of UK institutions in 2007.

Prior to joining Piper Jaffray in 2005, Fazeli worked at Nomura where he was part of a team that was ranked No. 1 in the Institutional Investor Survey of UK Small Cap Fund Managers in 2004.

Fazeli has a Ph.D. in Pharmacology and seven years post-doctoral experience.

AssociatesMichael J. Aitkenhead, M.D.011 44 20 [email protected]

Tracey J. West011 44 20 [email protected]

CompaniesAcambis PlcAddex Pharmaceuticals SaAlizyme PlcALK-Abello A/SAllergy TherapeuticsAntisoma PlcArdana PlcArk Therapeutics PlcBiocompatibles PlcBTG plcCuralogic A/SNicOx SAProtherics PlcStallergenes SAVectura Group PlcVernalis Plc


MEDICAL TECHNOLOGY: CARDIOVASCULAR/DIVERSIFIED

Thomas J. GundersonSenior Research Analyst612 [email protected]

Thomas Gunderson is a managing director and senior research analyst at Piper Jaffray, following cardiology and other medical device companies. Gunderson was named

a Wall Street Journal All-Star Analyst for medical stocks in 1996 and 2000.

Gunderson holds a bachelor’s degree from Carleton College, a master’s degree in cell biology from the University of Minnesota, and a master’s degree in business administration from the University of St. Thomas.

AssociatesCeline O. Cely612 [email protected]

Oleg Kradin612 [email protected]

Amy J. Sullivan612 [email protected]

CompaniesAccuray IncorporatedAmerican Medical Systems Holdings, Inc.Cutera, Inc.Cyberonics, Inc.Cytyc CorporationDexCom, Inc.ev3 Inc.Mentor CorporationTomoTherapy IncorporatedVNUS Medical Technologies, Inc.Volcano CorporationXTENT, Inc.


MEDICAL DEVICES

Suraj A. Kalia, CFASenior Research Analyst212 [email protected]

Suraj Kalia is a principal and senior research analyst at Piper Jaffray, specializing in medical device companies. Kalia was ranked No. 1 by Forbes and No. 5 in the Wall Street Journal’s Best on the Street survey for 2005 in the medical devices sector.

Kalia received a bachelor’s degree in chemical engineering from the Indian Institute of Technology-Bombay, a master’s degree in chemical engineering from the Stevens Institute of Technology-New Jersey and a master’s degree in business administration from the University of St. Thomas.

Kalia is a member of the Twin Cities Society of Security Analysts and the CFA Institute. He holds the Chartered Financial Analyst designation.

AssociatesRashni R. Sacks212 [email protected]

CompaniesABIOMED, Inc.AngioDynamics, Inc.BioSphere Medical, Inc.C.R. Bard, Inc.Micrus Endovascular CorporationNxStage Medical, Inc.Spectranetics Corporation (The)SurModics, Inc.Syneron Medical Ltd.Thoratec Corporation


Mark J. MullikinSenior Research Analyst612 [email protected]

Mark Mullikin is a vice president and senior research analyst at Piper Jaffray, where he focuses on ophthalmology and orthopedic companies.

Prior to joining Piper Jaffray in 2002, Mullikin was a manager at Deloitte Consulting, where he advised senior executives and LBO firms on strategy, finance and restructuring engagements. He also worked as a research associate for a Nobel Prize economist at the University of Chicago. Mullikin has co-authored several industry reports including “The Future of Treatments for Disc Disease,” “The Battle for Centerpulse” and “Plasma Proteins.”

He earned a bachelor’s degree in economics from the University of Chicago, where he was elected to Phi Beta Kappa, and a master’s degree in business administration from the MIT Sloan School of Management, which he attended as a Deloitte Scholar.

AssociatesCeline O. Cely John D. Crowther612 303-6437 612 [email protected] [email protected]

CompaniesAdvanced Medical Optics, Inc.Alcon Inc.Align Technology, Inc.ArthroCare CorporationBausch & Lomb Inc.CONMED CorporationCooper Companies, Inc. (The)CryoLife, Inc.DJO IncorporatedI-Flow CorporationIntegra LifeSciences Holdings CorporationKinetic Concepts, Inc.Kyphon Inc.LifeCell CorporationSmith & Nephew plcSonic Innovations, Inc.Stryker CorporationSymmetry Medical Inc.Vital Signs, Inc.Wright Medical Group, Inc.Zimmer Holdings, Inc.

MEDICAL TECHNOLOGY: OPHTHALMOLOGY, ORTHOPEDICS & DIVERSIFIED


LARGE CAP CARDIO/STRUCTURAL HEART DEVICES

Timothy B. NelsonSenior Research Analyst612 [email protected]

Tim Nelson is an assistant vice president and research analyst at Piper Jaffray, joining the firm in May 2000. His focus is on cardiovascular and diversified medical

technology companies. Nelson spent more than 20 years in the medical device industry, working for Medtronic, St. Jude Medical, and American Medical Systems Holdings, in a variety of finance and marketing functions.

Immediately prior to joining Piper Jaffray, Nelson was a vice president and senior research analyst covering medical devices at John G. Kinnard, Inc.

Nelson has a master’s degree in finance from the University of Michigan and a bachelor’s degree from Dartmouth College.

CompaniesAtriCure, Inc.ATS Medical, Inc.Boston Scientific CorporationEdwards Lifesciences CorporationGreatbatch, Inc.Intuitive Surgical, Inc.Medtronic, Inc.St. Jude Medical, Inc.ZOLL Medical Corporation


EUROPEAN BIOTECHNOLOGY

Richard J. Parkes, Ph.D.Senior Research Analyst011 44 20 [email protected]

Richard Parkes, Ph.D., is a vice president and senior research analyst covering European biopharmaceutical companies. He joined Piper Jaffray in 2006.

Previously, Parkes was a vice president at ING Wholesale Bank, where he was part of a biotechnology research team that was voted fifth in the 2005 Extel Pan-European Biotech Survey; he was ranked 13th as an individual in the same survey.

Parkes has a Ph.D. in molecular genetics from the Liverpool School of Tropical Medicine. He also worked as a post-doctoral research fellow at the Institute of Child Health, University College London on the development of gene therapy vectors.

AssociatesAsthika S. Goonewardene011 44 20 [email protected]

CompaniesActelion Ltd.ArpidaBasilea PharmaceuticaBioAlliance Pharma SAGenmab A/SGPC Biotech AGJerini AGPharmexa A/SProStrakan Group PlcSanthera PharmaceuticalsSkyePharmaTiGenix


MEDICAL DIAGNOSTICS

William R. Quirk, CFASenior Research Analyst612 [email protected]

William Quirk is a managing director and senior research analyst at Piper Jaffray, focusing on the medical diagnostics and life science tools sectors.

Prior to joining Piper Jaffray in 2006, Quirk worked in equity research at RBC Capital Markets in Minneapolis and at Payne Webber in New York.

Quirk received a bachelor’s degree in business from St. Norbert College and a master’s degree in business from the Carlson School of Management at the University of Minnesota. He holds the Chartered Financial Analyst designation.

AssociatesRebecca M. Carlson612 [email protected]

David C. Clair, CFA612 [email protected]

CompaniesApplied Biosystems GroupBeckman Coulter, Inc.Caliper Life Sciences Inc.Celera GroupCepheidDade Behring Holdings, Inc.Genomic Health, Inc.Gen-Probe IncorporatedHome Diagnostics, Inc.Immucor, Inc.Laboratory Corporation of America HoldingsMasimo CorporationMindray Medical International LimitedMonogram Biosciences, Inc.NeuroMetrix, Inc.QIAGEN N.V.Quest Diagnostics IncorporatedThird Wave Technologies, Inc.


SPECIALTY PHARMACEUTICALS

Gur-Arye Y. Roshwalb, M.D.Senior Research Analyst212 [email protected]

Gur Roshwalb is vice president and senior research analyst at Piper Jaffray, focusing on specialty pharmaceuticals companies.

Prior to joining Piper Jaffray in 2004, Gur was in private clinical practice in New York.

Gur received a bachelor’s degree from Columbia University and a master’s degree from the Albert Einstein College of Medicine. He subsequently trained in internal medicine at the Mount Sinai Medical Center, New York, where he served as chief resident. Gur is currently studying for his master’s degree in business administration at the Leonard N. Stern School of Business at New York University.

AssociatesMitul I. Desai212 [email protected]

CompaniesAlexza Pharmaceuticals, Inc.American Oriental Bioengineering, Inc.Endo Pharmaceuticals Holdings Inc.Forest Laboratories, Inc.Oscient Pharmaceuticals CorporationPharmion CorporationSalix Pharmaceuticals, Ltd.Sciele Pharma, Inc.Simcere Pharmaceutical GroupSomaxon Pharmaceuticals, Inc.


EUROPEAN MEDICAL TECHNOLOGY

Julie L. Simmonds, Ph.D.Senior Research Analyst011 44 20 [email protected]

Julie Simmonds, Ph.D., is a principal and senior research analyst covering European health care companies. She joined Piper Jaffray from Nomura

International in 2005.

Previously, Simmonds was Head of Life Sciences Research at Evolution Beeson Gregory. Simmonds was Starmine Healthcare Stock Picker of the year in 2003 and was ranked second in health care in the 2001 Reuters survey.

Simmonds has a Ph.D. in Microbiology from the University of Kent at Canterbury.

AssociatesAnthony J. Lerman, M.D.011 44 20 [email protected]

CompaniesAxis-ShieldCorin Group PlcGenetix Group PlcGyrus Group PlcInion OYIntercytex Group PlcOncoMethylome Sciences SAOptos plcSinclair PharmaceuticalsSpacelabs Healthcare, Inc.Tissue Science Laboratories Plc


BIOTECHNOLOGY: BIOPHARMACEUTICALS

Caroline Y. StewartSenior Research Analyst212 [email protected]

Caroline Stewart is a vice president and senior research analyst at Piper Jaffray, focusing on biotechnology companies.

Prior to joining Piper Jaffray, Stewart was a senior research analyst covering small- to mid-cap development-stage and early product biotech companies.

Stewart received a bachelor’s degree in chemistry from Columbia University and a master’s degree in chemistry and biology from Brandeis University.

AssociatesAnthony J. Cecchini212 [email protected]

CompaniesAcorda Therapeutics, Inc.Adolor CorporationAnesiva, Inc.Biogen Idec Inc.DURECT CorporationElan Corporation, plcImClone Systems IncorporatedNeurochem Inc.Nuvelo, Inc.OSI Pharmaceuticals, Inc.Progenics Pharmaceuticals, Inc.


DRUG DISCOVERY

Edward A. TenthoffSenior Research Analyst212 [email protected]

Ted Tenthoff is a principal and senior research analyst at Piper Jaffray, focused on the drug discovery sector of the biotech industry.

Prior to joining Piper Jaffray in 2003, Tenthoff worked at Think Equity Partners. Prior to that, he covered the genomics sector at Robertson, Stephens & Company, and was a medical technology analyst at Lehman Brothers. He was ranked No. 1 stock picker for life science tools and services in the 2006 Starmine Analyst Awards.

Tenthoff received a bachelor’s degree in investor relations from the University of Pennsylvania.

AssociatesChad J. Messer, Ph.D. Gurpreet S. Ratra212 284-9326 415 [email protected] [email protected]

CompaniesACADIA Pharmaceuticals Inc.Affymetrix, Inc.Alnylam Pharmaceuticals, Inc.Anadys Pharmaceuticals, Inc.Array BioPharma Inc.CombinatoRx, IncorporatedCuraGen CorporationCytori Therapeutics, Inc.deCODE genetics, Inc.Exelixis, Inc.Human Genome Sciences, Inc.Illumina, Inc.Infinity Pharmaceuticals, Inc.ISIS Pharmaceuticals Inc.Lexicon Pharmaceuticals, Inc.Millennium Pharmaceuticals, Inc.Myriad Genetics, Inc.Sangamo BioSciences, Inc.SGX Pharmaceuticals, Inc.Sirtris Pharmaceuticals, Inc.Vical IncorporatedZymoGenetics, Inc.


BIOTECHNOLOGY: THERAPEUTICS

Thomas A. WeiSenior Research Analyst212 [email protected]

Thomas Wei is a managing director and senior research analyst focusing on the biotechnology industry.

Prior to joining Piper Jaffray, Wei was a research associate at Deutsche Bank Securities and Adams, Harkness & Hill covering the biotechnology universe.

Wei is a graduate of Harvard University with AB degree in biochemistry. He also holds a MBA from Oxford University, where he was a Rhodes Scholar.

AssociatesMatthew S. Eckman212 [email protected]

Hongbo B. Lu, Ph.D.650 [email protected]

Elizabeth A. Naldi212 [email protected]

CompaniesAmylin Pharmaceuticals, Inc.Arena Pharmaceuticals, Inc.Auxilium Pharmaceuticals, Inc.CV Therapeutics, Inc.Genentech, Inc.Gilead Sciences, Inc.Incyte CorporationMannKind CorporationNeurocrine Biosciences Inc.Optimer Pharmaceuticals, Inc.Trimeris, Inc.ViroPharma Incorporated


HEALTH CARE SERVICES: INFORMATION TECHNOLOGY

Sean W. WielandSenior Research Analyst415 [email protected]

Sean Wieland is a managing director and a senior research analyst at Piper Jaffray, focusing on health care information technology and health care services.

Wieland has 13 years’ experience in health care information technology, including six years on the sell-side.

Prior to joining Piper Jaffray in 2005, Wieland was a senior research analyst at WR Hambrecht and Prudential Securities. Prior to joining the sell-side, he spent seven years in the industry, working in multiple roles at IDX Systems Corporation, most recently as a senior sales executive, where he learned firsthand about the need for technology in the health care setting.

Wieland earned his master’s degree in business administration and his bachelor’s degree in electrical engineering from the University of Vermont.

AssociatesLen Podolsky212 [email protected]

CompaniesAllscripts Healthcare Solutions, Inc.Cerner CorporationEclipsys CorporationEmageon Inc.Healthways, Inc.HLTH CorporationMatria Healthcare, Inc.Merge Technologies IncorporatedNighthawk Radiology Holdings, Inc.Omnicell, Inc.Phase Forward IncorporatedQuality Systems, Inc.TriZetto Group, Inc. (The)Vital Images, Inc.


HEAD OF INVESTMENT RESEARCH

Joel R. Denney, CFAHead of Investment Research612 [email protected]

Joel Denney is a managing director and head of Investment Research at Piper Jaffray. Before being named head of Investment Research, Denney was the

head of Fixed Income Research and covered aircraft finance with a focus on enhanced equipment trust certificates. Prior to joining the company in 1987, Denney was a portfolio manager for Minnesota Power in Duluth, Minn.

Denney earned his bachelor’s degree in business administration with concentrations in finance and economics from the University of Minnesota - Duluth and holds the Chartered Financial Analyst designation. He is a member of the CFA Institute and the CFA Society of Minnesota.

CO-HEAD OF INVESTMENT RESEARCH

George S. Dahlman, CFACo-Head of Investment Research612 [email protected]

George Dahlman is a managing director and co-head of Investment Research at Piper Jaffray. Dahlman joined the firm in 1982 as a senior research analyst,

specializing in food and agribusiness. In 2002 Dahlman was named research manager, administration.

Before he joined the Investment Research department of Piper Jaffray, he was a product line manager for International Harvester. From 1970 to 1980 he worked for the agricultural marketing research group of the Miller Publishing Company. Dahlman holds bachelor’s degrees in mathematics and psychology from Augsburg College. In 2001 he was recognized as a Distinguished Alumnus of that college. Dahlman holds the Chartered Financial Analyst designation and has been named a Wall Street Journal All-Star Analyst five times.


NOTES


Since 1895. Member SIPC and FINRA. Securities products and services offered in the United Kingdom by Piper Jaffray Ltd., authorised and regulated by the Financial Services Authority and a member of the London Stock Exchange.© 2007 Piper Jaffray & Co. 8/07 CM-07-1090 piperjaffray.com

Documents

The 19th Annual Health Care Conference - Piper Jaffray · The 19th Annual Health Care Conference November 27–29, 2007, New York City You are invited to attend